Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Boehringer Ingelheim named Top Employer in Thailand, across Southeast Asia, and South Korea for 2021 2021-01-25 10:00
Antengene Announces Approval of IND Application in China for ATG-010 (Selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study 2021-01-25 08:20
Nanoform's Clinical Study Indicates Positive Interim Results 2021-01-22 15:43
Nippon Express (China) Inks MOU on Logistics Business Partnership with Jointown Pharmaceutical Group Logistics 2021-01-22 14:00
Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) 2021-01-22 02:25
Envirotainer Opens First RAP e2 Station in Taipei 2021-01-21 16:14
Merck Announces Update on the INTR@PID Clinical Program Including Lung 037 Study 2021-01-20 23:35
Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content 2021-01-20 16:15
Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia 2021-01-19 08:00
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy 2021-01-18 19:00
Everest Medicines Announces Amended Agreement with Spero Therapeutics 2021-01-18 18:05
Modern Chinese Medicine Group Co., Ltd. announces its subscription results 2021-01-14 14:30
Ascentage Pharma Presents Updates on its Global Clinical Development at the J.P. Morgan 39th Annual Healthcare Conference 2021-01-14 09:32
Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine) 2021-01-13 09:00
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab injection) as First-Line Therapy in Hepatocellular Carcinoma (HCC) 2021-01-13 08:00
Kira Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference 2021-01-12 22:57
Beactica Therapeutics and University of Dundee announce collaboration to develop WRN inhibitors to target cancer 2021-01-12 17:26
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs 2021-01-12 12:26
Gannex Announces Positive Phase I Clinical Results on Its THR-β Agonist ASC41 2021-01-12 08:30
MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio 2021-01-12 04:38
1 183 184 185 186 187 280